---

Robert A. Bradway

Chairman and Chief Executive Officer, Amgen

In 2006, Robert joined Amgen as Vice President, Operations Strategy. He was appointed to the Amgen Board of Directors in October 2011, and became Chairman in January 2013 and CEO in May 2012. Before Amgen, he was a managing director at Morgan Stanley in London where he had responsibility for the firm’s banking department and corporate finance activities in Europe.

---

Part of the Power List 2016

The Top 100

The nominations are in and after considerable debate and analysis from our judging panel, we present The Power List 2016 – our second foray into the Top 100 most influential people in the world of drug development and manufacture.

Go to The Power List 2016